Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

about

Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.Efficiency of antibody therapy in demyelinating diseases.Pattern Recognition of the Multiple Sclerosis Syndrome.

P2860

Q38821407-5E456A8F-741B-4A78-A917-B05EAB9DC675 Q40045794-689FB02D-805A-443D-9742-3ED7657D3DB5 Q47096340-786CB9D5-9E8D-4351-A748-2A8A39A3BE5B

P2860

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

Item

http://www.wikidata.org/entity/Q36118869

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

@ast

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

@en

type

Item

label

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

@ast

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

@en

prefLabel

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

@ast

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

@en

P1476

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

@en

P2093

Elena Sherman

http://www.w3.org/2001/XMLSchema#string

May H Han

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

CD19 as an attractive target for antibody-based therapy

Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.

Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis.

Revised diagnostic criteria for neuromyelitis optica.

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.

P2888

s11940-015-0378-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11940-015-0378-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282573462

http://www.w3.org/2001/XMLSchema#string

P698

26433388

http://www.w3.org/2001/XMLSchema#string

P932

4592697

http://www.w3.org/2001/XMLSchema#string

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

about

P2860

P2860

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932